M. Nixon Ellis

M. Nixon Ellis

Geen lopende functies

Consumer Services
Health Technology
Commercial Services

Profiel

M.
Nixon Ellis
is President and Chief Executive Officer of Argolyn Bioscience, Inc. Most recently, he was President of Trimeris, Inc. Prior to joining Trimeris, he was President and Chief Operating Officer of Triangle Pharmaceuticals, Inc. from 1995 to 2000.
Dr. Ellis worked at Wellcome Co. and The Wellcome Foundation Ltd.
He was Assistant Director of Virology.
Previously, he held various positions at Burroughs Wellcome.
He has over 20 years of experience in research-based pharmaceutical and biotechnology companies.
Dr. Ellis received a BS degree in Biology from the University of South Carolina, an MS degree in Medical Microbiology, a PhD in Microbiology from the University of Georgia, and an MBA from the University of North Carolina.

Eerdere bekende functies van M. Nixon Ellis

BedrijvenFunctieEinde
President 26-11-2009
President -
Burroughs Wellcome Corporate Officer/Principal -
Wellcome Foundation Ltd Corporate Officer/Principal -
Hoofd Techniek/Wetenschap/O&O -
Ervaring van M. Nixon Ellis in detail bekijken

Opleiding van M. Nixon Ellis

University of Georgia Doctorate Degree
University of South Carolina Undergraduate Degree
The University of North Carolina at Charlotte Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van M. Nixon Ellis in detail bekijken

Connecties

6

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
PHASEBIO PHARMACEUTICALS, INC.

Health Technology

Bedrijven in privébezit6

Commercial Services

Health Technology

Health Technology

Wellcome Foundation Ltd

Commercial Services

Miscellaneous

Burroughs Wellcome

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. M. Nixon Ellis
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU